Synthesis of novel sulphamethoxazole derivatives and exploration of their anticancer and antimicrobial properties

被引:6
作者
Vaickelioniene, Rita [1 ]
Petrikaite, Vilma [2 ,3 ]
Vaskeviciene, Irena [4 ]
Pavilonis, Alvydas [5 ]
Mickevicius, Vytautas [1 ]
机构
[1] Kaunas Univ Technol, Dept Organ Chem, Kaunas, Lithuania
[2] Lithuanian Univ Hlth Sci, Inst Cardiol, Lab Drug Targets Histopathol, Kaunas, Lithuania
[3] Vilnius Univ, Inst Biotechnol, Life Sci Ctr, Vilnius, Lithuania
[4] Lithuanian Energy Inst, Lab Heat Equipment Res & Testing, Kaunas, Lithuania
[5] Lithuanian Univ Hlth Sci, Inst Microbiol & Virol, Kaunas, Lithuania
关键词
BIOLOGICAL EVALUATION; ISOXAZOLE; ANTIBACTERIAL; INHIBITORS; ANTAGONISTS; RESISTANCE; DESIGN; GROWTH; CELLS;
D O I
10.1371/journal.pone.0283289
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
A series of new derivatives based on sulfamethoxazole were designed and synthesized in this study. The structures of the new compounds were confirmed based on a comprehensive characterization of spectral data by applied IR and H-1 as well as C-13 NMR spectroscopy. The prepared compounds were tested for their anticancer and antimicrobial properties. Hydrazone 16b demonstrated convincing anticancer effect against all tested cell cultures such as human prostate carcinoma PPC-1 and human kidney carcinoma CaKi-1 cell lines, and human fibroblasts HF, n = 3. The most promising compound 16b showed higher activity against CaKi-1 cell line than the anticancer drugs axitinib and pazopanib used to treat renal cancer. Also, it was more active in the PPC-1 cell line compared to the approved PARP inhibitor Olaparib. Hydrazone 16b was also found to possess good antimicrobial properties against gram-positive bacteria strains of Staphylococcus aureus, Staphylococcus epidermidis, as well as Bacillus cereus.
引用
收藏
页数:22
相关论文
共 65 条
[1]  
Akili S, 2021, International Journal of Organic Chemistry, V11, P199, DOI [10.4236/ijoc.2021.114014, 10.4236/ijoc.2021.114014, DOI 10.4236/IJOC.2021.114014]
[2]   Design, synthesis and biological evaluation of 3,5-diaryl isoxazole derivatives as potential anticancer agents [J].
Aktas, Derya Anil ;
Akinalp, Gokcen ;
Sanli, Fatma ;
Yucel, Mehmet Ali ;
Gambacorta, Nicola ;
Nicolotti, Orazio ;
Karatas, Omer Faruk ;
Algul, Oztekin ;
Burmaoglu, Serdar .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2020, 30 (19)
[3]   Characterization and Biological Activity of Some New Derivatives Derived from Sulfamethoxazole Compound [J].
Alsahib, Sanaa A. .
BAGHDAD SCIENCE JOURNAL, 2020, 17 (02) :471-480
[4]   Synthesis, Antimicrobial and Antioxidant Activities of 2-Isoxazoline Derivatives [J].
Alshamari, Asma ;
Al-Qudah, Mahmoud ;
Hamadeh, Fedaa ;
Al-Momani, Lo'ay ;
Abu-Orabi, Sultan .
MOLECULES, 2020, 25 (18)
[5]   Isoxazole derivatives as anticancer agent: A review on synthetic strategies, mechanism of action and SAR studies [J].
Arya, Girish Chandra ;
Kaur, Kamalpreet ;
Jaitak, Vikas .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 221
[6]   Beta and Gamma Amino Acid-Substituted Benzenesulfonamides as Inhibitors of Human Carbonic Anhydrases [J].
Balandis, Benas ;
Simkunas, Tomas ;
Paketuryte-Latve, Vaida ;
Michailoviene, Vilma ;
Mickeviciute, Aurelija ;
Manakova, Elena ;
Grazulis, Saulius ;
Belyakov, Sergey ;
Kairys, Visvaldas ;
Mickevicius, Vytautas ;
Zubriene, Asta ;
Matulis, Daumantas .
PHARMACEUTICALS, 2022, 15 (04)
[7]   Exploration of Benzenesulfonamide-Bearing Imidazole Derivatives Activity in Triple-Negative Breast Cancer and Melanoma 2D and 3D Cell Cultures [J].
Balandis, Benas ;
Mickevicius, Vytautas ;
Petrikaite, Vilma .
PHARMACEUTICALS, 2021, 14 (11)
[8]   Synthesis and structure-affinity relationship of chlorinated pyrrolidinone-bearing benzenesulfonamides as human carbonic anhydrase inhibitors [J].
Balandis, Benas ;
Ivanauskaitc, Guoste ;
Smirnoviene, Joana ;
Kantminiene, Kristina ;
Matulis, Daumantas ;
Mickevicius, Vytautas ;
Zubriene, Asta .
BIOORGANIC CHEMISTRY, 2020, 97
[9]   3D Cell Culture Models as Recapitulators of the Tumor Microenvironment for the Screening of Anti-Cancer Drugs [J].
Barbosa, Melanie A. G. ;
Xavier, Cristina P. R. ;
Pereira, Ruben F. ;
Petrikaite, Vilma ;
Vasconcelos, M. Helena .
CANCERS, 2022, 14 (01)
[10]  
Bommagani MB, 2021, CHEM DATA COLLECT, V31, P100629, DOI [10.1016/j.cdc.2020.100629, DOI 10.1016/J.CDC.2020.100629, 10.1016/j.cdc.2020.100629]